Skip to main content
Clinical Trials/CTRI/2022/01/039856
CTRI/2022/01/039856
Active, not recruiting
Phase 2

Preclinical and clinical evaluation of the effect on oral administration of MEDATHAARI CHOORANAM along with external application of CHITHIRAMOOLA TAILAM in the management of BALAR KEELVAYU.

Dr P Ponsridharani0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr P Ponsridharani
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr P Ponsridharani

Eligibility Criteria

Inclusion Criteria

  • 2\.Pain and swelling of the joints
  • 3\.Morning stiffness
  • 4\.Rheumatoid factor positive or negative

Exclusion Criteria

  • 1\.Children above 12 years
  • 2\.Children below 5 years
  • 3\.Rheumatic fever
  • 4\.Psoriatic arthritis
  • 5\.Gouty arthritis
  • 6\. Neurological disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreHealth Condition 1: G819- Hemiplegia, unspecified
CTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childre
CTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecified
CTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsy
CTRI/2022/06/043082Dr P RAJAVATHANA40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.Health Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- Overweight
CTRI/2022/02/040297Dr J Mangalavalli40